Mark A. Schallenberger - 15 Nov 2025 Form 4 Insider Report for Xtant Medical Holdings, Inc. (XTNT)

Role
Chief Operating Officer
Signature
/s/ Amy Culbert, attorney-in-fact
Issuer symbol
XTNT
Transactions as of
15 Nov 2025
Net transactions value
$0
Form type
4
Filing time
18 Nov 2025, 16:55:10 UTC
Previous filing
17 Jan 2025
Next filing
18 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Schallenberger Mark A. Chief Operating Officer C/O XTANT MEDICAL HOLDINGS, INC., 664 CRUISER LANE, BELGRADE /s/ Amy Culbert, attorney-in-fact 18 Nov 2025 0001960742

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction XTNT Common Stock Award $0 +292,253 +77% $0.000000 670,866 15 Nov 2025 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction XTNT Performance Stock Units (PSUs) Award $0 +584,506 $0.000000 584,506 15 Nov 2025 Common Stock 584,506 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares will vest with respect to 73,063 shares on each of November 15, 2026, November 15, 2027, and November 15, 2028, and with respect to 73,064 shares on November 5, 2029 pursuant to a deferred stock unit (DSU) award granted under the Xtant Medical Holdings, Inc. Amended and Restated 2023 Equity Incentive Plan, conditioned upon the Reporting Person remaining an employee of Xtant through the applicable vesting date. The settlement of the vested shares underlying the DSU award has been deferred and will occur at a later date pursuant to the terms of the DSU award agreement. Each DSU represents a contingent right to receive one share of the Issuer's common stock.
F2 Includes an aggregate of 523,794 shares issuable upon vesting and settlement of restricted stock unit (RSU) awards or DSU awards granted under the Xtant Medical Holdings, Inc. Amended and Restated 2023 Equity Incentive Plan and 44,500 shares issuable upon vesting and settlement of RSU awards granted under the Xtant Medical Holdings, Inc. Amended and Restated 2018 Equity Incentive Plan, in each case conditioned upon the Reporting Person remaining an employee of Xtant through the applicable vesting dates.
F3 Each PSU represents a contingent right to receive one share of the Issuer's common stock. The PSUs will vest and become earned in one-third increments based on the achievement of specified stock price performance goals during a three-year performance period and subject to additional service-based vesting conditions.
F4 Represents the maximum number of shares that may be issued pursuant to the PSUs, which is 200% of the target number of shares (292,253).